» Articles » PMID: 21072264

Differential Fatty Acid Profile in Adipose and Non-adipose Tissues in Obese Mice

Overview
Specialty General Medicine
Date 2010 Nov 13
PMID 21072264
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a metabolic disease characterized by chronic inflammation. Early studies indicated that adipose tissue from obese mice contains more saturated fatty acids and that the saturated fatty acids activate TLR4-mediated inflammatory signaling, which contributes to inflammation in adipose tissue. In this study, we determined fatty acid profile in non-adipose tissues from obese (db/db) mice and compared with that from lean mice. Unexpectedly, in contrast to a significant increase in saturated and decrease in unsaturated fatty acid in adipose tissue from obese mice, the non-adipose tissues from obese mice exhibited a significant decrease in saturated and increase in unsaturated fatty acid compared with that from lean mice. The liver from obese mice had a 15% and 32% decrease in palmitic acid and stearic acid, and a 20% increase in linoleic acid; the spleen had a 32% and 60% decrease in palmitic acid and stearic acid, and a 70% and 50% increase in oleic acid and linoleic acid; and the pancreas had a 50% and 75% decrease in palmitic acid and stearic acid, and a 130% and 113% increase in oleic acid and linoleic acid. These data suggest that, different from adipose tissue where elevated saturated fatty acids contributes to inflammation, fatty acids per se in non-adipose tissues such as liver, spleen and pancreas may not contribute to inflammatory responses in obese mice.

Citing Articles

Hepatic FGF21: Its Emerging Role in Inter-Organ Crosstalk and Cancers.

Sui Y, Chen J Int J Biol Sci. 2022; 18(15):5928-5942.

PMID: 36263162 PMC: 9576513. DOI: 10.7150/ijbs.76924.


Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice.

Atchan A, Shivashankara S, Piazza S, Tchamgoue A, Beretta G, DellAgli M ACS Omega. 2022; 7(14):11914-11928.

PMID: 35449947 PMC: 9016817. DOI: 10.1021/acsomega.2c00050.


Stearidonic-Enriched Soybean Oil Modulates Obesity, Glucose Metabolism, and Fatty Acid Profiles Independently of Akkermansia muciniphila.

Segura Munoz R, Quach T, Gomes-Neto J, Xian Y, Pena P, Weier S Mol Nutr Food Res. 2020; 64(17):e2000162.

PMID: 32656952 PMC: 8606245. DOI: 10.1002/mnfr.202000162.


The Lymphatic Vasculature: Its Role in Adipose Metabolism and Obesity.

Escobedo N, Oliver G Cell Metab. 2017; 26(4):598-609.

PMID: 28844882 PMC: 5629116. DOI: 10.1016/j.cmet.2017.07.020.


Analysis of fatty acids in mouse tissue via in situ transmethylation with biochar.

Lee J, Fai Tsang Y, Oh J, Hong S, Kim C, Kwon E Environ Geochem Health. 2017; 41(4):1723-1728.

PMID: 28455818 DOI: 10.1007/s10653-017-9965-y.


References
1.
Hajer G, van Haeften T, Visseren F . Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008; 29(24):2959-71. DOI: 10.1093/eurheartj/ehn387. View

2.
Lappas M, Yee K, Permezel M, Rice G . Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology. 2004; 146(3):1491-7. DOI: 10.1210/en.2004-0809. View

3.
Kim J, Kim Y, Fillmore J, Chen Y, Moore I, Lee J . Prevention of fat-induced insulin resistance by salicylate. J Clin Invest. 2001; 108(3):437-46. PMC: 209353. DOI: 10.1172/JCI11559. View

4.
Barnes P, Karin M . Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336(15):1066-71. DOI: 10.1056/NEJM199704103361506. View

5.
Chow J, Young D, Golenbock D, Christ W, Gusovsky F . Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999; 274(16):10689-92. DOI: 10.1074/jbc.274.16.10689. View